Log In
Print this Print this

gevokizumab (S 78989, XOMA 052)

Also known as: formerly XMA005.2

  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionHumanized IgG2 mAb against IL-1 beta
Molecular Target Interleukin-1 (IL-1) beta
Mechanism of ActionInterleukin-1 (IL-1) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today